Published • loading... • Updated
Biogen Inc. (NASDAQ:BIIB) Stock Has Consensus Price Target of $231.07 According to Analysts
Summary by MarketBeat
1 Articles
1 Articles
Biogen Inc. (NASDAQ:BIIB) Stock Has Consensus Price Target of $231.07 According to Analysts
Shares of Biogen Inc. (NASDAQ:BIIB - Get Free Report) have earned a consensus rating of "Moderate Buy" from the thirty-two analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating
·Sioux Falls, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
